These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 38588966

  • 1. Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis.
    Mustafa HJ, Sambatur EV, Pagani G, D'Antonio F, Maisonneuve E, Maurice P, Zwiers C, Verweij JEJT, Flood A, Shamshirsaz AA, Jouannic JM, Khalil A.
    Am J Obstet Gynecol; 2024 Oct; 231(4):417-429.e21. PubMed ID: 38588966
    [Abstract] [Full Text] [Related]

  • 2. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
    Zwiers C, van der Bom JG, van Kamp IL, van Geloven N, Lopriore E, Smoleniec J, Devlieger R, Sim PE, Ledingham MA, Tiblad E, Moise KJ, Gloning KP, Kilby MD, Overton TG, Jørgensen DS, Schou KV, Paek B, Walker M, Parry E, Oepkes D, de Haas M.
    Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
    [Abstract] [Full Text] [Related]

  • 3. Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study.
    Maisonneuve E, Dugas A, Friszer S, Toly-Ndour C, Cariot L, Dhombres F, Cortey A, Mailloux A, Carbonne B, Jouannic JM.
    J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102119. PubMed ID: 33741541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
    Snelgrove JW, D'Souza R, Seaward PGR, Windrim R, Kelly EN, Ryan G.
    Fetal Diagn Ther; 2019 Sep; 46(6):425-432. PubMed ID: 31195389
    [Abstract] [Full Text] [Related]

  • 6. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
    Houston BL, Govia R, Abou-Setta AM, Reid GJ, Hadfield M, Menard C, Noyd J, Main S, Zarychanski R.
    Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
    [Abstract] [Full Text] [Related]

  • 7. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion.
    Fox C, Martin W, Somerset DA, Thompson PJ, Kilby MD.
    Fetal Diagn Ther; 2008 Dec; 23(2):159-63. PubMed ID: 18046076
    [Abstract] [Full Text] [Related]

  • 8. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
    Palfi M, Hildén JO, Matthiesen L, Selbing A, Berlin G.
    Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
    [Abstract] [Full Text] [Related]

  • 9. IVIG - is it the answer? Maternal administration of immunoglobulin for severe fetal red blood cell alloimmunisation during pregnancy: a case series.
    Connan K, Kornman L, Savoia H, Palma-Dias R, Rowlands S.
    Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):612-8. PubMed ID: 20070709
    [No Abstract] [Full Text] [Related]

  • 10. Intravenous immunoglobulin in the management of severe early onset red blood cell alloimmunisation.
    Vlachodimitropoulou E, Lo TK, Bambao C, Denomme G, Seaward GR, Windrim R, Tessier F, Kelly E, Van Mieghem T, Ryan G.
    Br J Haematol; 2023 Jan; 200(1):100-106. PubMed ID: 36100813
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intravenous fetal exchange transfusion before 22 weeks of gestation in early and severe red-cell fetomaternal alloimmunization.
    Poissonnier MH, Picone O, Brossard Y, Lepercq J.
    Fetal Diagn Ther; 2003 Jan; 18(6):467-71. PubMed ID: 14564122
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study.
    Sainio S, Nupponen I, Kuosmanen M, Aitokallio-Tallberg A, Ekholm E, Halmesmäki E, Orden MR, Palo P, Raudaskoski T, Tekay A, Tuimala J, Uotila J, Stefanovic V.
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):383-90. PubMed ID: 25603954
    [Abstract] [Full Text] [Related]

  • 15. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA, Ryan G, Seaward PG, Kelly EN, Fernandes BJ.
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Management of fetal hemolytic disease by cordocentesis. II. Outcome of treatment.
    Weiner CP, Williamson RA, Wenstrom KD, Sipes SL, Widness JA, Grant SS, Estle L.
    Am J Obstet Gynecol; 1991 Nov; 165(5 Pt 1):1302-7. PubMed ID: 1957851
    [Abstract] [Full Text] [Related]

  • 18. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
    Mimura K, Endo M, Takahashi A, Doi Y, Sakuragi M, Kiyokawa T, Taniguchi H, Kitabatake Y, Handa M, Tomimatsu T, Tomiyama Y, Isaka Y, Kimura T.
    Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
    Voto LS, Mathet ER, Zapaterio JL, Orti J, Lede RL, Margulies M.
    J Perinat Med; 1997 Jan; 25(1):85-8. PubMed ID: 9085208
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.